Genetic Signatures Limited

ASX Code



Pharmaceuticals- Biotechnology & Life Sciences

Investor Centre





Genetic Signatures is a specialist molecular diagnostics (MDx) company focused on the development and commercialisation of its proprietary platform technology, 3base™. Genetic Signatures has released a suite of real-time PCR based products for the routine detection of infectious diseases under the EasyScreen™ brand. This proprietary MDx technology provides hospitals and pathology laboratories with the ability to screen for a wide array of infectious pathogens with a high degree of specificity in a rapid throughput (time to result) environment. Genetic Signatures’ executive management team combines the scientific skills of the technology developers with the business acumen of industry veterans experienced in critical expansion markets.


Genetic Signatures (ASX:GSS) - TechKnow Invest Roadshow, August 2023
Genetic Signatures (ASX: GSS) - webinar presentation
Genetic Signatures (ASX: GSS) – Webinar Presentation
Test kits for infectious disease
Genetic Signatures: Australia’s Rapid Growth Diagnostics Company
Genetic Signatures Leverages New Screening Targets to EU and US Markets
Genetic Signatures (ASX:GSS) - Hidden Gems Webinar Presentation - 12/2/21
Genetic Signatures - ShareCafe Hidden Gems Webinar Presentation